ERBB2 and Patent ductus arteriosus: In similar fashion, a bispecific tribody which recognizes Vγ9 on γδ T cells and ERBB2 (HER2/neu) on pancreatic cancer cells enhanced γδ T cell cytotoxicity against PDA in vitro and in vivo (85).